| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.076 | 0.08 |